Delivery Order SPE2DB22D1202-SPE2DB24FUNC6

Award Date 1/22/24
Potential Completion Date 1/23/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Prilosec DR 10 mg suspension to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $2,498.94. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is May 3, 2024. The contract did not have a set-aside...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,808.82, is for the supply of Prilosec DR 10 mg suspension medication. The contract has an ultimate completion date of December 12, 2023 and is a firm fixed price delivery order. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award, valued at $6,930.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order contract for the provision of Prilosec DR 2.5 MG Suspension 30S, a pharmaceutical product. The contract has a Firm Fixed Price pricing type and an ultimate completion date of February 6, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of PRILOSEC DR 2.5 MG SUSPENSION 30S pharmaceutical products to the Defense Logistics Agency (DLA). The $3,510.88 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Prilosec DR 10 mg suspension. The $4,261.76 firm fixed-price contract has an ultimate completion date of December 15, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $8,750.17 firm fixed price delivery order is for the supply of 1,000 units of Omeprazole DR 40 mg capsules. No set-aside designation was used. Amerisourcebergen Drug Corp has a proven track record of providing pharmaceutical products and medical supplies to support DLA Troop Support...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $42,000 to Amerisourcebergen Drug Corporation for the supply of 90 capsules of 20mg omeprazole. Amerisourcebergen Drug Corporation will perform as the prime contractor, with corporate oversight provided by its parent company, Amerisourcebergen Corporation. Performance will take place in Conshohocken, Pennsylvania over a one day period from June 28 through June 29, 2023. No set aside designation or...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the delivery of Omeprazole 2 mg/mL suspension in 150 mL bottles. The contract, valued at $2,564.88, is a Firm Fixed Price Delivery Order with a completion date of September 12, 2024. The contract is not set aside for any specific business type. Amerisourcebergen, through its Corporate Office division, will provide this essential medical...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The award is for the delivery of 4,564,255,403 units of Omeprazole DR 40 mg Capsules, a prescription medication, over the period of April 2024 to April 2024 at a firm fixed price of $4,095.19. AmerisourceBergen Drug Corp is the prime contractor on this...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a firm fixed price delivery order for $1,347.84 from the Defense Logistics Agency (DLA) Troop Support Medical to supply 100 capsules of omeprazole 40 mg. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion by November 9, 2023. No set-aside designation was applied to this order, which was awarded under an indefinite delivery contract to provide...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB24FUNC6
    Delivery Order

This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA). The $1,348.70 firm fixed price contract is for the provision of Prilosec DR 10 mg pharmaceutical suspension. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and is providing these pharmaceutical products from its corporate office in Conshohocken, Pennsylvania. This contract does not have a set-aside designation and is part of DLA's efforts to supply pharmaceuticals and medical materials to support military treatment programs and facilities. Amerisourcebergen Drug Corp has a track record of receiving federal contract awards from the DLA and other agencies to provide a range of pharmaceutical and medical products and services.

Generated 4/22/24, 9:42 AM